期刊
ONCOIMMUNOLOGY
卷 3, 期 11, 页码 -出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/21624011.2014.962401
关键词
pancreatic cancer; tumor immunotherapy; tumor vaccines
Single agent immunotherapy is effective against several cancers, but has failed against poorly immunogenic cancers, including pancreatic cancer. Evaluation of pancreatic tumors following treatment with an experimental vaccine (Lutz et al. Cancer Immunology Research 2014) suggests that vaccination primes the tumor microenvironment (TME) for checkpoint-inhibitor immunotherapy, and supports a new platform for evaluating checkpoint-inhibitors in poorly immunogenic cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据